Back to top
  • Uncovering more options in cancer immunotherapy

    Jeudi, 10 janvier 2019 11:30:02 De: Sciencedaily Dernière modification: Jeudi, 24 janvier, 2019 - 08:05

    If scientists want to boost immune cells' ability to kill cancer cells, then vast libraries of small molecules are potentially available. A new paper shows a platform to sort through them, plus validation. One of the hits: IAP antagonist birinapant, which is already in clinical trials (coincidentally).